Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
With ~3.9 million Canadians living with diabetes (9.7% of the population) and over 6% of adults with prediabetes, this approval is expected to significantly improve access to high-quality, affordable treatment
Angiogenesis Stimulates new blood vessel formation, improving healing
Jul 17, 2025 Cutting-edge treatment approach addresses neurobehavioral symptoms in neurofibromatosis type 1 A new treatment for neurobehavioral symptoms caused by neurofibromatosis type 1, or NF1, has shown promise
Given the magnitude of the obesity crisis in the US, there are still millions of individuals who could benefit from our high-quality, affordable, personalized approach to the condition
Retatrutide has no Drug Identification Number, no Natural Product Number, and no Homeopathic Drug Number issued by Health Canada, and no New Drug Submission has been filed as of the date of this listing in May 2026
Serious adverse events with tirzepatide are rare in clinical trials, and the medication has demonstrated good safety over 612 months of use
US$ 21.39
US$ 26.30
US$ 20.79
US$ 20.89
US$ 28.39
US$ 22.86
US$ 26.06
